sb 216763 has been researched along with Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anyanwu, AC; Bentley, JK; Deng, H; Hershenson, MB; Lei, J; Pinsky, DJ | 1 |
Mozaffari, MS; Schaffer, SW | 1 |
2 other study(ies) available for sb 216763 and Hypertension
Article | Year |
---|---|
Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase.
Topics: Actins; Bone Morphogenetic Protein 4; Endothelin-1; Epidermal Growth Factor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypertension; Hypertrophy; Indoles; Lithium Chloride; Maleimides; Muscle Contraction; Potassium Chloride; Pulmonary Artery; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Serotonin; Signal Transduction; Transforming Growth Factor beta1 | 2010 |
Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Topics: Animals; Cardiotonic Agents; Cyclosporine; Diazoxide; Disease Models, Animal; Glyburide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertension; In Vitro Techniques; Indoles; Lithium Chloride; Male; Maleimides; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Pressure | 2008 |